Interview with Dr Michael Weller (Zurich) about the Phase-III EGFRvIII Vaccine Trial on Newly Diagnosed EGFRvIII-Positive Glioblastoma

Abacioglu U

Verlag für Medizin und Wirtschaft

Mobile Version

A- | A | A+

Werbung

Figures and Graphics

Abacioglu U

Interview with Dr Michael Weller (Zurich) about the Phase-III EGFRvIII Vaccine Trial on Newly Diagnosed EGFRvIII-Positive Glioblastoma

European Association of NeuroOncology Magazine 2013; 3 (3): 155-156

PDF Figures

Figure

Maximize View	ACT IV Figure 1: Trial scheme Keywords: ACT IV, scheme